The Trump administration plans to pump millions of dollars into producing more medications in the U.S. as the coronavirus pandemic heightens longstanding concerns about the fragility of the global drug supply chain.
The coronavirus pandemic has affected virtually every country in the world, but the ability to combat it with essential medicines varies widely. Low- and middle-income countries (LMICs) are finding it especially tough to access medicines, and ensure the safety and quality of those products that are available.
The coronavirus pandemic is bringing about radical changes in global supply chains. But whether companies can draw on the lessons of the present to handle the challenges of future such events is still in question.
COVID-19 is about to put the global trading system through its most dramatic stress-test since World War II, with supply lines for essential food and medical goods entering a critical phase as the pandemic peaks in the U.S. and Europe.
Carmakers might seem unlikely candidates to build ventilators for coronavirus victims. But in fact they may be quite well-suited to churn out the highly intricate medical devices that are in critically short supply.
Tuesday, April 21, 2020 12:00 to Tuesday, July 21, 2020 12:00
Tired of Non-Stop Firefighting to Sell and Ship Product? Don’t Miss This Webinar.
To get out of crisis mode, companies are turning to Integrated Tactical Planning (ITP).
In this webinar, you’ll discover how middle managers use ITP to routinely re-align and re-optimize product, demand, and supply plans over the near term. Execution becomes far more reliable, and crises are minimized.
In this webinar, you will also learn:
How Integrated Tactical Planning works
Symptoms that indicate your company may benefit from ITP
Real life examples and lessons learned from organizations executing ITP
Todd Ferguson, Principal, Oliver Wight Americas
Dawn Howarth, Partner, Oliver Wight EAME
Rod Hozack, Partner, Oliver Wight Asia Pacific